Alternative Energy
Federal Grand Jury Indicts Oren Shachar in Hospice Fraud Case
The 16-count indictment accuses the Los Angeles hospice operator and two alleged collaborators of healthcare fraud, aggravated identity theft, illegal kickbacks, trafficking Medicare identifiers, and moving criminally derived money through a luxury-vehicle transaction
WASHINGTON, D.C. — A federal grand jury has indicted Los Angeles-area hospice operator Oren David Shachar and two alleged collaborators in a sprawling Medicare case that prosecutors say converted vulnerable patients, grieving families, and stolen medical identities into approximately $27.7 million in fraudulent government claims.
The 16-count case, filed in the Central District of California, accuses Shachar, Jeannie Choi, and Abraham Shin of participating in a scheme that allegedly enrolled people who were not terminally ill, billed for people who were already dead, and used kickbacks to sustain a profitable hospice pipeline.
According to the federal grand jury’s 16-count indictment, Medicare paid approximately $26.9 million of the roughly $27.7 million submitted through four hospice companies that prosecutors identify as businesses Shachar owned, controlled, and operated across greater Los Angeles.
The allegations remain unproven; every defendant is presumed innocent unless guilt is established beyond a reasonable doubt, and the indictment represents the government’s accusation rather than a judicial finding about what Shachar, Choi, or Shin actually did.
The Oren Shachar Hospice Fraud Indictment
Shachar, 59, of Van Nuys, was arrested June 18 alongside Shin, 66, of Corona, while Choi, 57, of Torrance, was arrested several days later, according to prosecutors, who said all three were charged within the same coordinated federal enforcement case.
The indictment’s first count alleges conspiracy to commit healthcare fraud, while counts two through nine identify eight alleged executions of that fraud involving claims attributed to Gentle Touch Hospice Care, Oxford Hospice Care, Art of Hospice, and Holly Trinity Hospice.
Counts ten through twelve allege aggravated identity theft involving the names, Social Security numbers, and Medicare identification numbers of three beneficiaries, whose initials appear in the charging document to protect personal information while connecting each identity count with an underlying healthcare-fraud count.
Count thirteen accuses Shachar of conducting a monetary transaction exceeding $10,000 in criminally derived property, while counts fourteen and fifteen allege illegal referral payments and count sixteen alleges the unlawful sale and distribution of nine Medicare beneficiary identification numbers.
Together, those counts create a prosecution theory extending far beyond inaccurate billing, because the government alleges an interconnected enterprise involving patient recruitment, medical-record fabrication, identity misuse, referral compensation, beneficiary inducements, data sales, and movement of alleged proceeds into an expensive personal asset.
Federal prosecutors said Shachar and Shin were arraigned after their arrests and released on bond, while a June 23 announcement listed an August 11 trial date, although federal trial calendars can change through later court orders, motions, or scheduling conferences.
Four Hospices at the Center of the Case
The indictment identifies Gentle Touch Hospice Care in Valley Glen, Oxford Hospice Care in Montclair, Art of Hospice in Encino, and Holly Trinity Hospice in Glendale as the four outpatient providers allegedly used to submit claims under Shachar’s ownership or control.
Court filings trace his alleged connection with those companies across several years, beginning with Art of Hospice as early as October 2019, followed by Oxford, Gentle Touch, and Holly Trinity, which prosecutors say he operated beginning around April 2023.
Prosecutors contend Shachar submitted at least eleven Medicare enrollment applications certifying that claims would cover medically necessary services delivered as represented and would not arise from kickbacks, representations that now sit at the center of the government’s intent evidence.
Those enrollment certifications matter because Medicare provider status is not merely a billing credential, but an agreement to follow program rules, disclose ownership, preserve truthful records, avoid prohibited remuneration, and seek reimbursement only for eligible care actually furnished to qualified beneficiaries.
The charging document places the alleged conspiracy between February 2021 and March 2026, although it describes Shin’s alleged participation as beginning no later than March 2025 and Choi’s alleged involvement as running from no later than May 2025 through at least November 2025.
That chronology allows prosecutors to present the case as an established hospice-billing operation that allegedly expanded through marketers and access to funeral-home information, rather than as a short-lived series of disconnected billing errors or isolated administrative failures.
How Medicare Hospice Eligibility Works
Medicare hospice coverage generally requires a physician to certify that a beneficiary is terminally ill, meaning the individual is expected to live six months or less if the illness follows its normal course, while the beneficiary must knowingly elect palliative hospice care.
That election carries important consequences because hospice emphasizes comfort, symptom management, nursing services, counseling, equipment, and related support, while Medicare generally stops covering treatment intended to cure the terminal condition once the beneficiary elects the hospice benefit.
The indictment alleges Shachar personally met Medicare beneficiaries whom he knew were not terminally ill and described hospice as care focused on improving their quality of life, while concealing the required terminal certification and potential limitations on curative benefits.
If proven, that alleged concealment would make the case about informed consent as well as public money, because a beneficiary who misunderstands hospice enrollment may unknowingly alter access to physicians, treatment options, and Medicare coverage during a medically consequential period.
Prosecutors further allege that ineligible living beneficiaries were enrolled and kept within the hospices so claims could continue, converting a benefit designed for end-of-life support into what the government characterizes as a recurring reimbursement stream driven by recruitment rather than clinical necessity.
Cash, Gifts, and a Patient Recruitment Pipeline
The indictment alleges Shachar directly or indirectly offered beneficiaries as much as $400 per month to remain enrolled, supplementing cash with groceries, alcohol, personal-care supplies, medical equipment, televisions, massages, and furniture that included reclining armchairs.
Beneficiaries were also allegedly offered $100 or $200 for each additional patient they referred, while patient marketers could receive approximately $700 for every living beneficiary during each month that the person remained enrolled and was billed to Medicare.
Federal anti-kickback rules treat remuneration as more than a technical compliance issue because money or valuable goods tied to federally reimbursed referrals can distort medical decisions, reward volume over need, and steer patients toward services that may be unnecessary or unsuitable.
Counts fourteen and fifteen focus on two alleged $300 payments, one offered and paid to Choi for a September 2025 beneficiary referral and another offered and paid to Shin for a January 2026 referral, providing specific transactions within the broader conspiracy narrative.
The government must still prove the necessary criminal intent and every statutory element, but prosecutors will likely use the alleged payment patterns, enrollment representations, communications, claims, and associated records to argue that remuneration was deliberately connected with federally funded hospice referrals.
Dead Beneficiaries and Backdated Medical Records
The indictment’s most disturbing allegations concern people who had already died, whose identifying details were allegedly obtained through a funeral-home employee and then used to create the appearance that hospice evaluations, certifications, and enrollment had occurred before death.
Prosecutors say Choi obtained access through her work at an unnamed, California-licensed funeral home, after which Choi and Shin allegedly sent Shachar photographs of identification documents and information through text messages and WhatsApp communications.
The transferred information allegedly included names, dates of birth, Social Security numbers, Medicare identifiers, dates and times of death, primary-care physician names, and next-of-kin details, creating a data package capable of supporting claims and apparently credible retrospective patient files.
When a deceased person appeared to have been eligible for Medicare hospice coverage while alive, the indictment says Shachar, a nurse, or Choi would contact surviving relatives, collect additional health information, and seek records from the beneficiary’s recent hospital visits.
Shachar then allegedly directed a nurse, a physician identified anonymously in the indictment, and others to create false electronic records stating that nurses had evaluated the beneficiaries while alive and that a physician had certified them as terminally ill.
Payments for deceased-beneficiary referrals allegedly ranged from $1,000 to $3,000, amounts substantially higher than some living-patient referral payments and therefore potentially useful to prosecutors seeking to demonstrate the commercial value placed on identities that could support retrospective hospice claims.
Rules Allegedly Designed to Avoid Detection
Prosecutors allege Shachar imposed special criteria for deceased referrals, including that the person had died at home, had died within five days of a marketer contacting him, and had not been receiving services from another hospice at death.
The indictment says accurate death dates and times were important to the alleged operation because they enabled Shachar to prepare compatible records and arrange for a surviving relative to sign hospice enrollment paperwork after the beneficiary had already died.
Those alleged selection rules appear designed, according to the government’s theory, to reduce obvious conflicts with institutional documentation, competing hospice claims, and timelines that automated Medicare reviews or human auditors could more readily identify as impossible.
Prosecutors also claim the deceased-patient billing helped conceal an unusually high live-discharge rate, a potential indicator that too many enrolled patients were not actually near death, while helping offset Medicare’s annual per-patient spending limit for hospice providers.
This combination of clinical records, beneficiary identifiers, exact death information, family signatures, and strategically timed claims illustrates why modern medical identity theft and related identity crimes can produce harms extending well beyond conventional credit-card or bank-account fraud.
Why Aggravated Identity Theft Changes the Stakes
Aggravated identity theft allegations are especially consequential because the statute addresses unauthorized use of another person’s identifying information during specified felonies, and a conviction ordinarily carries a mandatory prison term that must run consecutively to punishment for the underlying offense.
Counts ten through twelve identify three instances from August and November 2025 in which prosecutors say names, Social Security numbers, and Medicare identifiers were transferred, possessed, or used without lawful authority in connection with charged healthcare-fraud executions.
The allegations also demonstrate why the identities of deceased people remain valuable to criminals, since death does not immediately erase government identifiers, medical histories, insurance eligibility, family relationships, or the administrative records used to evaluate claims across complex healthcare systems.
For families, posthumous identity misuse can create a uniquely painful collision between bereavement and bureaucracy, requiring relatives to answer questions about services their loved one never received while confronting documents that may falsely portray the person’s final days.
Legitimate identity changes use lawful procedures, accurate government records, and transparent compliance obligations, whereas taking over another person’s identity or relying on fabricated credentials can expose participants to fraud, identity theft, forfeiture, immigration, and imprisonment consequences across multiple jurisdictions.
An Alleged Sale of Medicare Numbers
Count sixteen goes beyond using identifiers inside the four hospices by alleging that, on March 6, 2025, Shachar sold, arranged the sale, and distributed nine Medicare beneficiary identification numbers to an unnamed physician for $12,500.
That allegation broadens the government’s narrative from internal billing misconduct to alleged trafficking in health identifiers, suggesting prosecutors believe beneficiary data functioned as a marketable commodity that could be separated from one provider and monetized elsewhere.
Healthcare identifiers are particularly sensitive because they can unlock reimbursement, support invented treatment histories, contaminate authentic patient records, and facilitate additional schemes long after an initial breach, making early anomaly detection essential for both program integrity and patient safety.
Investigators commonly compare claims across providers, dates, locations, diagnoses, death records, enrollment periods, and ownership networks, allowing apparently routine transactions to become powerful evidence when the same beneficiary, marketer, bank account, or electronic trail repeatedly connects suspicious activity.
Following the Alleged Proceeds
Count thirteen alleges that Shachar transferred $15,000 from a Holly Trinity Hospice bank account as part of a down payment for a lease-to-own Rolls-Royce Phantom, while knowing the funds represented proceeds of unlawful healthcare fraud.
That criminal-proceeds count gives prosecutors a financial transaction distinct from the underlying claims, permitting them to show jurors how money allegedly moved from a Medicare-funded business account toward a luxury purchase rather than remaining an abstract number within reimbursement data.
Local reporting by FOX 11 Los Angeles also displayed government-provided images described as a yacht and a Bentley Continental GT purchased with alleged fraud proceeds, although the indictment itself specifically identifies the $15,000 Rolls-Royce transaction charged in count thirteen.
The indictment includes forfeiture allegations seeking property traceable to relevant offenses or substitute assets of equivalent value when original proceeds cannot be found, have been transferred to third parties, placed beyond the court’s jurisdiction, diminished, or commingled beyond practical division.
Forfeiture remains contingent upon conviction and applicable legal findings, yet its inclusion signals that the prosecution seeks not only imprisonment or fines but also recovery of assets that the government contends were obtained through, derived from, or involved in criminal conduct.
A Case Within the 2026 National Takedown
The Shachar prosecution was announced during the 2026 National Healthcare Fraud Takedown, a coordinated action that federal officials said produced charges against 455 defendants, including 90 doctors and licensed professionals, across 56 federal districts and 45 states and territories.
Authorities attributed more than $6.5 billion in alleged false claims to the nationwide cases and reported more than $182 million seized in cash, vehicles, jewelry, and other property, although those nationwide totals should not be confused with assets or losses specifically attributed to Shachar.
The broader operation involved the Federal Bureau of Investigation, the Department of Health and Human Services inspector general, federal prosecutors, Medicare administrators, state Medicaid Fraud Control Units, and international partners, reflecting the increasingly data-driven and border-spanning character of healthcare enforcement.
Federal officials also announced provider suspensions, billing-privilege revocations, civil settlements, exclusions, and payment holds, demonstrating how criminal prosecutions now operate alongside administrative interventions intended to stop suspicious reimbursements before lengthy court proceedings reach final judgments.
The Justice Department said its healthcare strike-force program has charged more than 6,200 defendants since 2007 in cases involving over $45 billion billed to public programs and private insurers, figures that place the Los Angeles hospice allegations within a sustained national enforcement campaign.
What Prosecutors Must Prove
Despite the indictment’s detail, prosecutors must prove beyond a reasonable doubt that each defendant knowingly joined or executed the charged conduct, possessed the required fraudulent or unlawful intent, and committed the specific acts assigned to that defendant under each count.
Defense lawyers may challenge the interpretation of medical eligibility, the accuracy and context of communications, attribution of business records, knowledge of employee conduct, links between payments and referrals, calculation of alleged losses, and the government’s characterization of financial transactions.
Healthcare cases can become technically demanding because jurors must distinguish poor documentation, administrative noncompliance, negligent oversight, disputed medical judgment, and billing mistakes from deliberate deception, while separately evaluating the knowledge and intent of every charged participant.
The indictment’s selected claim examples do not alone prove the full $27.7 million allegation, meaning prosecutors will likely rely on a much larger body of claims data, bank records, messages, enrollment documents, medical files, witness testimony, and expert analysis.
Shachar and his co-defendants may contest that evidence, present alternative explanations, seek suppression or exclusion of particular materials, negotiate resolutions, or proceed to trial, while the court determines admissibility and jurors ultimately decide whether the government has met its burden.
Why the Oren Shachar Case Matters
The Oren Shachar hospice fraud case highlights a structural vulnerability created when trusted provider credentials, sensitive patient information, and recurring government payments intersect, because a convincing false record can travel through multiple administrative systems before any single anomaly becomes decisive.
It also underscores the human cost concealed inside claims statistics, since hospice decisions concern dying patients, worried relatives, physicians, and caregivers whose confidence depends upon truthful certification, informed consent, protected records, and services chosen according to need rather than remuneration.
For beneficiaries and families, reviewing Medicare statements, questioning unfamiliar hospice entries, protecting medical identifiers, and reporting services that were never requested or received can help investigators detect patterns before false information becomes embedded across additional claims and provider records.
For legitimate hospice operators, the indictment is a warning that ownership transparency, referral oversight, staff access controls, death-record reconciliation, patient consent, clinical certification, marketing compensation, and transaction monitoring must function as active safeguards rather than paperwork completed only for inspections.
The government’s case will now move through the federal judicial process, where allegations involving $27.7 million, four hospices, deceased beneficiaries, cash inducements, stolen identifiers, and luxury spending must be tested under evidentiary rules and the constitutional presumption of innocence.
Whatever verdict ultimately emerges, the indictment already presents a stark enforcement narrative: prosecutors believe hospice fraud can be built from small referrals, private messages, compromised identities, backdated records, and repeated claims until the accumulated conduct becomes a multimillion-dollar federal prosecution.


